Tag Archives: industry

The Science Publishing Industry as Turbo-Capitalism. A manifesto.

The modern science publishing industry operates much like turbo-capitalism — a system driven by profit maximization, consolidation of power, and resistance to regulation. What once served as a collective effort to disseminate knowledge has turned into a multibillion-dollar business controlled by a few dominant publishers such as Elsevier, Springer Nature, and Wiley. These companies have commercialized access to knowledge itself, transforming the public good of science into a high-priced commodity.

The evolution of the publishing system followed the classic pattern of enshittification. At first, science served the peers, then the  users — offering access, visibility, and academic communication. Then publishers as peripheral service provider began to exploit those users to favor their paying institutional customers, tightening control over access and pricing. Finally, they turn on those very customers, extracting maximum profit while degrading service, fairness, and trust, until the entire ecosystem becomes a hollow structure of metrics and monetization.

Just as financial elites resisted government oversight, major publishers oppose reforms that would curb their profits. They lobby against open-access mandates, hide profit structures behind opaque pricing, and maintain control through prestige and impact metrics that entrench their market dominance. Their profits — often higher than those of Apple or Google — depend on free academic labor: scientists write, review, and edit for free, while universities must then pay to read their own work back.

Equity and fairness are collateral damage in this system. Article processing charges reaching thousands of dollars exclude poorer institutions and researchers from full participation. The ideal of open, global science is replaced by a tiered system where access and influence depend on wealth and affiliation.

Equally revealing is the industry’s attitude toward corrections and retractions. In a healthy scientific ecosystem, acknowledging and correcting errors is vital. But in the turbo-capitalist logic of publishing, retractions resemble market regulations — they threaten reputation, weaken brand value, and risk financial loss. Publishers therefore often delay or resist corrections, preferring to protect the façade of flawless output over the integrity of the scientific record.

This distorted environment also shapes scientific behavior itself. Way too many self-assigned researchers, under immense pressure to build careers in a metric-driven system, quickly learn how to “game the system”. Even without proper training or deep experience, they chase citation counts, impact factors, and quantity over quality — optimizing for visibility rather than understanding. The system rewards the appearance of productivity, not the slow and  rather uncertain process of genuine discovery.

Thus, the science publishing industry reproduces the same pathologies seen in unregulated capitalism: profit before accountability, personality show before truth, and career before fairness. In this turbo-capitalist model, we have learned the price of everything — but the value of nothing. To restore science to its purpose — the open pursuit of truth — it is not enough to call for open access. The entire system must be rebalanced away from speculative prestige and back toward collective responsibility, transparency, and genuine public knowledge.

 

 

CC-BY-NC Science Surf 12.10.2025, access 17.10.2025

Desynchronizing peer review and publication

researchprofessionalnews

The Plan S open-access initiative has announced its support for newly emerging ways of producing research papers, in which peer review takes place independently from publication in journals or on platforms.

plan S is widely known for their last major announcement

on September 12, 2018, UBS confirmed a sell rating for shares in Elsevier (RELX). Elsevier stock lost 13% between August 28 and September 19, 2018 alone

so hopefully the stock market will respond again by selling out Elsevier.

 

CC-BY-NC Science Surf 8.07.2022, access 17.10.2025

An open letter to EAACI / PAAM 2019 organizers

Together with many other colleagues I was astonished about the Nestle booth at EAACI / PAAM 2019 conference in Florence.

The advertisement of Nestle for the NAN HA formula (“state-of-the-art routine infant formula“, „proven to reduce the risk of atopic dermatitis“, „long term effects up to 15 years of age“) along with other milk marketing violates recommendations of the WHO and other medical organisations about breast-feeding. None of the claims made is justified from a scientific viewpoint.

Having paid 650 € entry fee for a 3 day conference, it is also not acceptable that Dr Antonella Muraro (Padua) explains in Symposium 9 “Special products for cow’s milk allergy“ that if Nestle would not be sponsoring the event, the congress fees would be even higher.

At present, there is no generally accepted benefit of any baby food on long-term allergy prevention while also the therapeutic benefit is questionable. Commercial baby food may even increase later allergy by including supplements that are itself allergenic.

We therefore recommend a review of the EAACI ethics guidelines of industry sponsorship, and an immediate action against further participation of Nestle at future EAACI allergy congresses.

 

CC-BY-NC Science Surf 20.10.2019, access 17.10.2025